General Information of the Compound
Compound ID |
CP0413009
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
[4-(hydroxymethyl)piperidin-1-yl]-(3-methyl-1-naphthalen-1-ylpyrazol-4-yl)methanone
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C21H23N3O2
|
||||||||||||||||||
Molecular Weight |
349.434
|
||||||||||||||||||
Canonical SMILES |
Cc1nn(cc1C(=O)N1CCC(CO)CC1)-c1cccc2ccccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H23N3O2/c1-15-19(21(26)23-11-9-16(14-25)10-12-23)13-24(22-15)20-8-4-6-17-5-2-3-7-18(17)20/h2-8,13,16,25H,9-12,14H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
RLPIOUQPDRLZLX-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01019, 5-hydroxytryptamine receptor 2B
Protein ID: PT00939, 5-hydroxytryptamine receptor 2C